MedTrace Logo

Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer

NCT06876610 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-03-14

No results posted yet for this study

Summary

The purpose of this study is to construct an auxiliary diagnostic model for breast cancer by methylation markers. The study will collect blood and tissue samples from participants with breast cancer and benign disease for whole-genome methylation sequencing. It will screen methylation markers and develop a methylation auxiliary diagnosis model to distinguish between breast cancer and non-cancer.

Conditions

  • Breast Cancer Screening

Sponsors & Collaborators

  • Chinese Academy of Medical Sciences

    collaborator OTHER

  • Geneplus-Beijing Co. Ltd.

    lead INDUSTRY

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-15
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06876610 on ClinicalTrials.gov